Macelignan
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Macelignan
- DrugBank Accession Number
- DB14129
- Background
Macelignan is an NSAID with antioxidant, free radical scavenging, and neuroprotective activities.
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 328.408
Monoisotopic: 328.167459253 - Chemical Formula
- C20H24O4
- Synonyms
- (8R,8'S)-7-(3,4-methylenedioxyphenyl)-7'-(4-hydroxy-3-methoxyphenyl)-8,8'-dimethylbutane
- Anwulignan
- Austrobailignan 6
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image OHUI White-skin Science White Perfection Cream 0.15 mL/100mL Topical Lg Household & Health Care Ltd. 2010-09-02 2011-09-02 US Ohui White-skin Science White Perfection Emulsion 0.105 mL/100mL Topical Lg Household & Health Care Ltd. 2010-10-28 2011-06-01 US OHUI White-skin Science White Perfection Serum Cream 0.11 mL/100mL Topical Lg Household & Health Care Ltd. 2010-09-02 2011-06-01 US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image O HUI white-skin science white calming mask Macelignan (0.01 g/100g) + Diacetyl benzoyl lathyrol (0.11 g/100g) Liquid Topical Lg Household & Health Care Ltd. 2010-07-19 2011-07-19 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image O HUI white-skin science white calming mask Macelignan (0.01 g/100g) + Diacetyl benzoyl lathyrol (0.11 g/100g) Liquid Topical Lg Household & Health Care Ltd. 2010-07-19 2011-07-19 US OHUI White-skin Science White Perfection Macelignan (0.15 mL/100mL) Cream Topical Lg Household & Health Care Ltd. 2010-09-02 2011-09-02 US Ohui White-skin Science White Perfection Macelignan (0.105 mL/100mL) Emulsion Topical Lg Household & Health Care Ltd. 2010-10-28 2011-06-01 US OHUI White-skin Science White Perfection Serum Macelignan (0.11 mL/100mL) Cream Topical Lg Household & Health Care Ltd. 2010-09-02 2011-06-01 US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as dibenzylbutane lignans. These are lignan compounds containing a 2,3-dibenzylbutane moiety.
- Kingdom
- Organic compounds
- Super Class
- Lignans, neolignans and related compounds
- Class
- Dibenzylbutane lignans
- Sub Class
- Not Available
- Direct Parent
- Dibenzylbutane lignans
- Alternative Parents
- Methoxyphenols / Phenylpropanes / Benzodioxoles / Phenoxy compounds / Methoxybenzenes / Anisoles / Alkyl aryl ethers / 1-hydroxy-2-unsubstituted benzenoids / Oxacyclic compounds / Acetals show 1 more
- Substituents
- 1-hydroxy-2-unsubstituted benzenoid / Acetal / Alkyl aryl ether / Anisole / Aromatic heteropolycyclic compound / Benzenoid / Benzodioxole / Dibenzylbutane lignan skeleton / Ether / Hydrocarbon derivative show 11 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 8PP3614Z43
- CAS number
- 107534-93-0
- InChI Key
- QDDILOVMGWUNGD-UONOGXRCSA-N
- InChI
- InChI=1S/C20H24O4/c1-13(8-15-4-6-17(21)19(10-15)22-3)14(2)9-16-5-7-18-20(11-16)24-12-23-18/h4-7,10-11,13-14,21H,8-9,12H2,1-3H3/t13-,14+/m0/s1
- IUPAC Name
- 4-[(2S,3R)-4-(2H-1,3-benzodioxol-5-yl)-2,3-dimethylbutyl]-2-methoxyphenol
- SMILES
- COC1=CC(C[C@H](C)[C@H](C)CC2=CC3=C(OCO3)C=C2)=CC=C1O
References
- General References
- Not Available
- External Links
- ChemSpider
- 8579683
- BindingDB
- 90735
- 1872381
- ChEBI
- 94153
- ChEMBL
- CHEMBL254071
- ZINC
- ZINC000013108863
- Wikipedia
- Macelignan
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Topical Cream Topical 0.15 mL/100mL Emulsion Topical 0.105 mL/100mL Cream Topical 0.11 mL/100mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00285 mg/mL ALOGPS logP 4.86 ALOGPS logP 5.13 Chemaxon logS -5.1 ALOGPS pKa (Strongest Acidic) 10.28 Chemaxon pKa (Strongest Basic) -4.5 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 47.92 Å2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 92.91 m3·mol-1 Chemaxon Polarizability 37.11 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five No Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-052b-0491000000-c1ad60c906a5677c0ecd Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-004i-0019000000-cc1eb785180594706449 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0032-0295000000-1db574fec5dee4e45011 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-000j-0951000000-30d79b7f16243a7c8808 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-03g0-0593000000-aa48d520a72385601241 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-004j-0291000000-3047b461e90faa83b780 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 197.8402424 predictedDarkChem Lite v0.1.0 [M-H]- 195.3736424 predictedDarkChem Lite v0.1.0 [M+H]+ 198.2802424 predictedDarkChem Lite v0.1.0 [M+H]+ 195.3157424 predictedDarkChem Lite v0.1.0 [M+Na]+ 197.4942424 predictedDarkChem Lite v0.1.0 [M+Na]+ 195.2161424 predictedDarkChem Lite v0.1.0
Drug created at June 26, 2018 13:16 / Updated at June 12, 2020 16:53